Prefrontal γ-Aminobutyric Acid Levels in Never-Medicated Individuals With Chronic Schizophrenia
Authors:
- 1 October 2023
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 80 (10) , 1075-1077
Abstract
This cross-sectional study analyzes spectroscopy data for long-term, never-medicated patients with schizophrenia to examine their levels of γ-aminobutyric acid (GABA) compared with those of healthy controls.Keywords
This publication has 6 references indexed in Scilit:
- Medial Frontal Cortex GABA Concentrations in Psychosis Spectrum and Mood Disorders: A Meta-analysis of Proton Magnetic Resonance Spectroscopy StudiesBiological Psychiatry, 2022
- Psychotic DisordersNew England Journal of Medicine, 2018
- Prefrontal Cortical Gamma-Aminobutyric Acid Transmission and Cognitive Function: Drawing Links to Schizophrenia from Preclinical ResearchBiological Psychiatry, 2015
- Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression studyMolecular Psychiatry, 2015
- Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance SpectroscopyArchives of General Psychiatry, 2012
- Elevated Gamma-Aminobutyric Acid Levels in Chronic SchizophreniaBiological Psychiatry, 2010